Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis

Xiong, Bin; Ma, Li; Cai-quan, Zhang; Cheng, Yong

doi:10.1016/j.jss.2014.01.027

Cited by 93 publications

(79 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One metaanalysis by Xiong et al looking at RCS versus LCS performing TME for rectal cancer, found that robotic TME was associated with lower rates of positive CRM as compared to laparoscopic TME (p=0.04). The difference in DRM was not found to be statistically significant in that study (p=0.36) [26]. The meta-analyses performed by Yang et al and Trastulli et al found no statistically significant difference in positive CRM or DRM between the two groups.…”

Section: Oncologic Outcomesmentioning

confidence: 61%

A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer

et al. 2015

View full text Add to dashboard Cite

The goal of this review was to compare long-term oncologic outcomes of robotic versus laparoscopic resection of colorectal cancer. A literature search was performed using PubMed, EMBASE, Cochrane, and Medline (2002-2014). Search terms: laparoscopic, robotic, rectal, colon, surgery, oncologic, and outcomes. Studies comparing overall and disease free survival of robotic versus laparoscopic surgery for colorectal cancer were included. Meta-analysis was performed using OpenMeta[Analyst] for Windows 8. Five studies were identified reporting on overall survival, disease free survival, lymph node extraction, and distal and circumferential resection margin. Three hundred and seventeen patients underwent robotic resection and 368 underwent laparoscopic resection, with similar demographics. Operative times were longer with robotic resections, with no difference in estimated blood loss (EBL) or length of stay. The disease stage was distributed similarly in both groups. Similar numbers underwent neoadjuvant therapy. Laparoscopic resection was associated with 3.2 mm larger distal resection margins (p=0.04) and 2.2 more lymph nodes removed (p=0.001), but with equivalent circumferential resection margin status. Disease-free and overall survival was equivalent. Robotic and laparoscopic surgery for colorectal cancer offer comparable overall and disease free survival. Laparoscopic surgery offered a slight advantage in operative time, distal margin, and lymph node yield. Larger, prospective trials are needed to confirm the equivalence of these approaches.

show abstract

Section: Oncologic Outcomesmentioning

confidence: 61%

A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer

et al. 2015

View full text Add to dashboard Cite

show abstract

“…The publications by Xiong et al and Wang et al reported superior oncological outcomes in favor of robotics, with CRM positivity rates of 2.74% versus 5.78% for robotics and laparoscopy, respectively. [27][28][29] Analysis of the pooled data also revealed a significantly lower conversion rate (OR 0.23, 95% CI 0.10-0.52, p=0.0004) and a lower incidence of erectile dysfunction (OR 0.09, 95% CI 0.02-0.41, p=0.002) in robotic TME. These studies attribute the superior results of robotics to (1) a stable three-dimensional high-definition camera system and three additional working arms that are entirely controlled by the surgeon, (2) tremor filtering, (3) endowrist instruments with 7° of movement, and (4) an ergonomic operating position.…”

Section: Use Of the XI In Tmementioning

confidence: 83%

“…[20][21][22] All seven articles in the 2014 publication by Xu et al were included in a 2015 publication by Chang et al, and some of these articles also contributed to half of the meta-analysis by Zarak et al 11,12,[22][23][24][25][26] Between 2014 and 2016, three different journals separately published meta-analyses on robotic versus laparoscopic rectal cancer surgery -all included the same eight studies and 1229 patients. [27][28][29] Two of these publications were authored by the same group. As a testament to sound statistics, all three articles arrived at the same results and conclusions.…”

mentioning

confidence: 99%

The da Vinci Xi: a review of its capabilities, versatility, and potential role in robotic colorectal surgery

Ngu¹,

Tsang²,

Koh³

2017

RSRR

View full text Add to dashboard Cite

Abstract:The Xi is the latest da Vinci surgical system approved for use in colorectal surgery. With its novel overhead architecture, slimmer boom-mounted arms, extended instrument reach, guided targeting, and integrated auxiliary technology, the Xi manages to address several limitations of earlier models. The versatility of this new system allows it to be implemented in a wide range of colorectal procedures -from complex multiquadrant colectomies to challenging mesorectal dissections in the pelvis. While commonly criticized for its cost and prolonged operative time, robotic colorectal surgery holds the potential for enhanced ergonomics, superior precision, and a reduction in the learning curve involved in training an expert surgeon. This review appraises the existing literature on robotic colorectal surgery while elaborating how the improved capabilities of the Xi serve to usher in a new era of minimally invasive colorectal surgery.

show abstract

“…At present, the greatest utilization for continued advancements with robotic colorectal surgery is centered on techniques and outcomes for total mesorectal excision (TME) [108,109]. Although 45 % of colectomies are performed laparoscopically in the USA, less than 10 % of rectal resections are performed using a minimally invasive approach.…”

Section: Colorectal Surgerymentioning

confidence: 99%

SAGES TAVAC safety and effectiveness analysis: da Vinci® Surgical System (Intuitive Surgical, Sunnyvale, CA)

et al. 2015

View full text Add to dashboard Cite

show abstract

Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis

Cited by 93 publications

References 65 publications

A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer

A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer

The da Vinci Xi: a review of its capabilities, versatility, and potential role in robotic colorectal surgery

SAGES TAVAC safety and effectiveness analysis: da Vinci® Surgical System (Intuitive Surgical, Sunnyvale, CA)

Contact Info

Product

Resources

About